Ocular insert

• US 6,264,971 B1
• Filed: 11/04/1999
• Issued: 07/24/2001
• Est. Priority Date: 11/04/1999
• Status: Expired due to Fees

• Current Assignee: Dayshad Darougar, Sohrab Darougar
• Original Assignee: BTG International Limited (Boston Scientific Corporation)
• Inventors: Darougar, Dayshad, Darougar, Sohrab
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): Pulliam, Amy E.
• Application Number:
  US09/428,967
• Time in Patent Office: 628 Days
• Field of Search: 424/427, 424/428, 424/429, 424/422
• US Class Current: 424/427
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61K 9/0051 Ocular inserts, ocular implants

Abstract

A flexible ocular insert device adapted for the controlled sustained release of a drug upon insertion into the upper or lower fornix of the eye. The device comprises an elongate body of a polymeric material including two end portions, wherein the body contains a pharmaceutically active ingredient, and wherein the device has a length of at least 8 mm and a maximum diameter not exceeding 1.9 mm. The device is sufficiently flexible to allow it to bend along the curvature of the eye within the upper or lower fornix upon its being positioned so that the longitudinal axis of the device is generally parallel to the transverse diameter of the eyeball, and the device does not extend onto any visible portion of the eyeball. Each of the end portions of the device is tapered towards the extremities of the device.

Claims

1. A flexible ocular insert device adapted for the controlled sustained release of a drug upon insertion into the upper or lower fornix of the eye, said device comprising an elongate body of a polymeric material including two end portions said body containing a pharmaceutically active ingredient, said device having a length of at least 8 mm and a maximum diameter not exceeding 1.9 mm, wherein said device is sufficiently flexible to allow it to bend along the curvature of the eye within the upper or lower fornix upon being positioned so that the longitudinal axis of said device is generally parallel to the transverse diameter of the eyeball, the device does not extend onto any visible portion of the eyeball, and in which each of said end portions is tapered towards the extremities of the device.

2. A device according to claim 1, in which the end portions are each in the form of a right circular cone.

3. A device according to claim 1, in which the end portions are each in the form of an oblique circular cone.

4. A device according to claim 1 in which the apex of each end portion is rounded.

5. A device according to claim 1, wherein the length of the device is from 8 to 25 mm for use in the lower fornix to suit the eyes of different sizes such as infants, children and adults.

6. A device according to claim 1, wherein the length of the device is from 8 to 35 mm for use in the upper fornix to suit the eyes of different sizes such as infants, children and adults.

7. A device according to claim 6, wherein the diameter of the device is from 0.5 to 1.9 mm to suit the eyes of different sizes such as infants, children and adults.

8. A device according to claim 1, wherein the body is tubular and the mechanism of drug release is by diffusion through an outer wall of the device.

9. A device according to claim 1, wherein the mechanism of drug release is by osmosis.

10. A device according to claim 1, wherein the mechanism of drug release is bioerosion.

11. A device according to claim 1, wherein the mechanism of drug release is by diffusion including possible drug dissolution.

12. A device according to claim 1, wherein the polymeric material is a silicone elastomer.

13. A device according to claim 1, wherein the polymeric material is made of hydrogel components.

14. A device according to claim 1, wherein the polymeric material is a methacrylate or hydroxymethacrylate based material.

30. A method for the controlled sustained release of one or more drugs into the eye over a period of time comprising inserting a flexible ocular insert device according to claim 1 or 15 into position in the upper or lower fornix of the eye and allowing said device to remain in the fornix for drug release during said period of time.

31. A device according to claim 7 incorporating one or more radial protrusions, wherein the diameter of the device including said protrusions is from 0.5 to 1.9 mm to suit the eyes of different sizes such as infants, children and adults.

15. A device adapted for the controlled sustained release of two or more drugs upon insertion into the upper or lower fornix of the eye, said device comprising an elongated body of a polymeric material including two end portions said body containing pharmaceutically active ingredient, said device having a length of at least 8 mm and a maximum diameter not exceeding 1.9 mm, wherein said device is sufficiently flexible to allow it to bend along the curvature of the eye within the upper or lower fornix upon being positioned so that the longitudinal axis of said device is generally parallel to the transverse diameter of the eyeball, and which at least two distinct portions of the device include respective distinct ones of said drugs.

16. A flexible insert device as claimed in claim 15 and in which said end portions are tapered towards respective extremities of the device.

17. A device according to claim 16, in which the end portions are each in the form of a right circular cone.

18. A device according to claim 16, in which the end portions are each in the form of an oblique circular cone.

19. A device according to claim 16 in which the apex of each end portion is rounded.

20. A device according to claim 16, wherein the length of the device is from 8 to 25 mm for use in the lower fornix to suit the eyes of different sizes such as infants, children and adults.

21. A device according to claim 16, wherein the length of the device is from 8 to 35 mm for use in the upper fornix to suit the eyes of different sizes such as infants, children and adults.

22. A device according to claim 16, wherein the diameter of the device is from 0.5 to 1.9 mm to suit the eyes of different sizes such as infants, children and adults.

23. A device according to claim 16, wherein the body is tubular and the mechanism of drug release is by diffusion through an outer wall of the device.

24. A device according to claim 16, wherein the mechanism of drug release is by osmosis.

25. A device according to claim 16, wherein the mechanism of drug release is biorerosion.

26. A device according to claim 16, wherein the mechanism of drug release is by diffusion including possible drug dissolution.

27. A device according to claim 16, wherein the polymeric material is a silicone elastomer.

28. A device according to claim 16, wherein the polymeric material is made of hydrogel components.

29. A device according to claim 16, wherein the polymeric material is a methacrylate or hydroxymethacrylate based material.

32. A device according to claim 22 incorporating one or more radial protrusions, wherein the diameter of the device including said protrusions is from 0.5 to 1.9 mm to suit the eyes of different sizes such as infants, children and adults.